Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
John M. and Mary Jo Boler Assistant Professor, Department of Biological Sciences at University of Notre Dame
Dr. Xin Lu develops novel insights into the genetic and molecular mechanisms of prostate tumor progression, tumor immunology and treatment resistance, and apply such knowledge to enhance efficacy of therapeutic intervention to benefit prostate cancer patients. Through his PhD research at Princeton University and Postdoc research at MD Anderson Cancer Center, Dr. Lu has made many contributions to the mechanistic understanding and therapy target identification of breast cancer and prostate cancer. He has published over 20 research and review articles, including the most recent publication in Nature reporting targeting immunosuppressive myeloid cells to enhance immunotherapy for advanced prostate cancer. His research team at University of Notre Dame and Indiana University Simon Cancer Center is actively investigating in-depth mechanisms of myeloid cell regulation and targeting in prostate cancer and other forms of malignancy including rare cancers. Dr. Lu sincerely welcomes opportunities of collaboration from both academic and industrial arenas.